These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26183647)

  • 1. Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia.
    Salvianti F; Inversetti A; Smid M; Valsecchi L; Candiani M; Pazzagli M; Cremonesi L; Ferrari M; Pinzani P; Galbiati S
    Placenta; 2015 Sep; 36(9):996-1001. PubMed ID: 26183647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RASSF1A in maternal plasma as a molecular marker of preeclampsia.
    Papantoniou N; Bagiokos V; Agiannitopoulos K; Kolialexi A; Destouni A; Tounta G; Kanavakis E; Antsaklis A; Mavrou A
    Prenat Diagn; 2013 Jul; 33(7):682-7. PubMed ID: 23526657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
    Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM
    Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal plasma cell-free DNA in the prediction of pre-eclampsia.
    Rolnik DL; O'Gorman N; Fiolna M; van den Boom D; Nicolaides KH; Poon LC
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):106-11. PubMed ID: 25252010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of placenta-derived RASSF1A sequence expression in maternal plasma for pre-eclampsia].
    Wang J; Yang J; Wu X; Mu Y; Li S; Cui K; Wang X; Zhao F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):25-8. PubMed ID: 24510557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction.
    Karapetian АО; Baev ОR; Sadekova АА; Krasnyi АМ; Sukhikh GT
    Reprod Sci; 2021 May; 28(5):1563-1569. PubMed ID: 33475978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes.
    Poon LC; Musci T; Song K; Syngelaki A; Nicolaides KH
    Fetal Diagn Ther; 2013; 33(4):215-23. PubMed ID: 23466432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein.
    Saraswathy S; Sahai K; Yadav TP; Arora D; Mendiratta SL; Naqvi SH; Biswas S; Krishnan M; Abraham KM
    Pregnancy Hypertens; 2016 Oct; 6(4):306-312. PubMed ID: 27939474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative detection of the hypermethylated RASSF1A gene in maternal plasma of pre-eclampsia].
    Wang J; Zhao F; Wu Y; Liu R; Mu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):73-6. PubMed ID: 20140873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free fetal DNA in maternal circulation after chorionic villous sampling.
    Di Tommaso M; Seravalli V; Salvianti F; Bussani C; Pasquini L; Cordisco A; Pinzani P
    Prenat Diagn; 2013 Jul; 33(7):695-9. PubMed ID: 23658144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics.
    Zejskova L; Jancuskova T; Kotlabova K; Doucha J; Hromadnikova I
    Exp Mol Pathol; 2010 Dec; 89(3):241-7. PubMed ID: 20868679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia.
    Tsui DW; Chan KC; Chim SS; Chan LW; Leung TY; Lau TK; Lo YM; Chiu RW
    Prenat Diagn; 2007 Dec; 27(13):1212-8. PubMed ID: 17994635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal-specific hypermethylated RASSF1A quantification in pregnancy.
    Saraswathy S; Sahai K; Arora D; Krishnan M; Mendiratta SL; Biswas S; Abraham KM
    J Matern Fetal Neonatal Med; 2017 Apr; 30(7):849-853. PubMed ID: 27165812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency.
    Hromadnikova I; Zejskova L; Kotlabova K; Jancuskova T; Doucha J; Dlouha K; Krofta L; Jirasek JE; Vlk R
    DNA Cell Biol; 2010 Jun; 29(6):295-301. PubMed ID: 20235876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma levels of hypermethylated RASSF1A gene sequences in pregnant women with intrahepatic cholestasis.
    Yi P; Yin N; Zheng Y; Jiang H; Yu X; Yan Y; Liu Q; Xiao F; Li L
    Cell Biochem Biophys; 2013; 67(3):977-81. PubMed ID: 23579583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma.
    Zhao F; Wang J; Liu R; Yang J; Cui K; Wu Y; Guo J; Mu Y; Wang X
    Prenat Diagn; 2010 Aug; 30(8):778-82. PubMed ID: 20661892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Changes of Fetal-Derived Hypermethylated RASSF1A and Septin 9 Sequences in Maternal Plasma.
    Zhang L; Wang CM; Zhou WP; Chen QP; Zhou S; Lei W; Deng H; Zhang L; Liu GC
    Reprod Sci; 2021 Apr; 28(4):1194-1199. PubMed ID: 33417202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes.
    Amaral LM; Sandrim VC; Kutcher ME; Spradley FT; Cavalli RC; Tanus-Santos JE; Palei AC
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric analysis of cell-free DNA in melanoma patients.
    Salvianti F; Pinzani P; Verderio P; Ciniselli CM; Massi D; De Giorgi V; Grazzini M; Pazzagli M; Orlando C
    PLoS One; 2012; 7(11):e49843. PubMed ID: 23209607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
    Cotter AM; Martin CM; O'leary JJ; Daly SF
    Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.